Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe

Citation
A. Mocroft et al., Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe, AIDS, 13(8), 1999, pp. 943-950
Citations number
41
Categorie Soggetti
Immunology
Journal title
AIDS
ISSN journal
02699370 → ACNP
Volume
13
Issue
8
Year of publication
1999
Pages
943 - 950
Database
ISI
SICI code
0269-9370(19990528)13:8<943:AIAIPM>2.0.ZU;2-K
Abstract
Objectives: To describe changes in haemoglobin over time and to determine t he joint prognostic value of the current haemoglobin, CD4 lymphocyte count and viral load among patients from across Europe. Patients: The analysis included 6725 patients from EuroSIDA, an observation al, prospective cohort of patients with HIV from across Europe. Methods: Normal haemoglobin was defined as haemoglobin greater than 14 g/dl for men and 12 g/dl for women; mild anaemia was 8-14 g/dl for men and 8-12 g/dl for women; severe anaemia was defined as less than 8 g/dl for both ma les and females. Linear regression techniques were used to estimate the ann ual change in haemoglobin; standard survival techniques were used to descri be disease progression and risk of death. Results: At recruitment, to the study, 40.4% had normal levels of haemoglob in, 58.2% had mild anaemia and 1.4% had severe anaemia. At 12 months after recruitment, the proportion of patients estimated to have died was 3.1% [95 % confidence interval (CI) 2.3-3.9] for patients without anaemia, 15.9% for patients with mild anaemia (95% CI 14.5-17.2) and 40.8% for patients with severe anaemia (95% CI 27.9-53.6; P < 0.0001). In a multivariate, time-upda ted Cox proportional hazards model, adjusted for demographic factors, AIDS status and each antiretroviral treatment as time-dependent covariates, a 1 g/dl decrease in the latest haemoglobin level increased the hazard of death by 57% [relative hazard (RH) 1.57; 95% CI 1.41-1.75; P < 0.0001], a 50% dr op in the most recent CD4 lymphocyte count increased the hazard by 51% (RH 1.51; 95% CI 1.35-1.70; P < 0.0001) and a log increase in the latest viral load increased the hazard by 37% (RH 1.37; 95% CI 1.15-1.63; P = 0.0005). Conclusions: Severe anaemia occurred infrequently among these patients but was associated with a much faster rate of disease progression. Among patien ts with similar CD4 lymphocyte counts and viral load, the latest value of h aemoglobin was a strong independent prognostic marker for death. (C) 1999 L ippincott Williams & Wilkins.